-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Yield10 Bioscience, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2019 to Q1 2023.
- Yield10 Bioscience, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
- Yield10 Bioscience, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
- Yield10 Bioscience, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $165K, a 358% increase from 2021.
- Yield10 Bioscience, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $36K, a 35.7% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)